Skip to main content
. Author manuscript; available in PMC: 2010 Dec 29.
Published in final edited form as: Technol Cancer Res Treat. 2010 Apr;9(2):139–147. doi: 10.1177/153303461000900203

Table I.

Summary of microarray and next-generation sequencing assays in profiling DNA methylome.

Restriction enzyme Bisulfite modification DNA precipitation Advantages Limitations Ref.
Microarray-based methylation profiling
Endonuclease restriction-based microarray analysis
CHARM McrBC - - Identify hyper- or hypomethylated CpG sites Moderate resolution; limit to restriction enzymes digested sites 22, 23
DMH BstUI/HpaII - - 10, 11
HELP HpaII/MspI - - 16, 17
MCAM SmaI/XmaI - - 12
McrBC McrBC - - 19, 20
MMASS McrBC/cocktail - - 21
PMAD HpaII/MspI - - 15
Bisulfite conversion-based microarray analysis
MSO - Yes - Cost efficiency Moderate resolution 24
Bead array - Yes - 28, 29
Affinity-based microarray analysis
MeDIP - - Yes Efficient assays to CGIs and repetitive sequences Less sensitive to CpG poor sites 30
MIRA - - Yes Depending on MBD binding ability 32-34
Sequencing-based methylation profiling
BS-seq - Yes - High resolution Higher cost at this stage 39
MethylC-Seq - Yes 44, 45
RRBS MspI Yes - Each sequencing-read contains at least one CpG site Limit to restriction enzymes digested sites 41
HELP-seq HpaII/MspI - - 17
Padlock probe Could be Yes - Quantify DNA methylation in a smaller genome fraction with high resolution at this stage Limit to probes designing 42, 43
MeDIP-seq - - - Moderate resolution Less sensitive to CpG poor sites 31